Belite Bio, Inc. (BLTE)

175.06 -1.85 (-1.05%) USD  |  NASDAQ  |  Feb 11, 16:00
175.35 +0.29 (+0.17%) After-Hours: 20:00
More

Belite Bio Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for BLTE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
Ocugen, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
IDEAYA Biosciences, Inc. Upgrade
Terns Pharmaceuticals, Inc. Upgrade